Hyper-vascular change and formation of advanced glycation endproducts in the peritoneum caused by methylglyoxal and the effect of an anti-oxidant, sodium sulfite.
about
Targeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis.Methylglyoxal Induced Basophilic Spindle Cells with Podoplanin at the Surface of Peritoneum in Rat Peritoneal Dialysis ModelInhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosisEffluent Tenascin-C Levels Reflect Peritoneal Deterioration in Peritoneal Dialysis: MAJOR IN PD Study.Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition.Cannabinoid receptors as therapeutic targets for dialysis-induced peritoneal fibrosis.Attenuation of methylglyoxal-induced peritoneal fibrosis: immunomodulation by interleukin-10.New insights into therapeutic strategies for the treatment of peritoneal fibrosis: learning from histochemical analyses of animal models.Methylglyoxal augments intracellular oxidative stress in human aortic endothelial cells.Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats.Acidic organelles mediate TGF-β1-induced cellular fibrosis via (pro)renin receptor and vacuolar ATPase trafficking in human peritoneal mesothelial cells.Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis.
P2860
Q33655394-3CE77803-66C7-488A-A052-42AC9162BFFEQ35612422-6231C960-BCD9-472E-955C-0A372C2DDD69Q36302660-D2A99188-DA2D-4C90-ACAF-BE3278A7DF02Q36386616-6CD333CB-AD0B-440E-A8E4-342F2F0EA98AQ39033979-7D80C141-CDB9-4453-8365-2A6DA4C35847Q39215034-8DAE73CC-B43A-4F74-989B-C7AD27369E76Q41363398-550C6A27-F617-41C1-98B9-19F9646EA10FQ42002311-8036D3BB-8E10-4B1C-BBBB-20F6ED709E38Q43249355-910E38BC-C7C6-4A7D-BEB0-E2B496EF8E77Q46368377-BA52C86A-724A-4AF0-9F0B-463A7EDD3E73Q49872492-C811AB45-47EA-40A4-85C1-7DE52E7289ECQ54972703-B6A7A526-FBDE-4AB2-BEA1-57EC00011559
P2860
Hyper-vascular change and formation of advanced glycation endproducts in the peritoneum caused by methylglyoxal and the effect of an anti-oxidant, sodium sulfite.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Hyper-vascular change and form ...... anti-oxidant, sodium sulfite.
@en
Hyper-vascular change and form ...... anti-oxidant, sodium sulfite.
@nl
type
label
Hyper-vascular change and form ...... anti-oxidant, sodium sulfite.
@en
Hyper-vascular change and form ...... anti-oxidant, sodium sulfite.
@nl
prefLabel
Hyper-vascular change and form ...... anti-oxidant, sodium sulfite.
@en
Hyper-vascular change and form ...... anti-oxidant, sodium sulfite.
@nl
P2093
P356
P1476
Hyper-vascular change and form ...... anti-oxidant, sodium sulfite.
@en
P2093
Asahi Sakai
Masaaki Nakayama
Miwako Numata
Tatsuo Hosoya
P304
P356
10.1159/000074065
P577
2003-10-10T00:00:00Z